Dissolved and financials
CVR: 25812921
Previous names: ENKAM PHARMACEUTICALS A/S
DKK -275,740
Gross profit
Net result: DKK -293,665
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 15 July 2021
CVR · view overview
1 employee
CVR · 2019
Director role ended: Pernille Bigaard
CVR · 11/01/2021
View the full event history
ENKAM PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company has been dissolved on 15 July 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ENKAM PHARMACEUTICALS A/S. The company has 1 employee (2019). In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity in the 2018 report amounted to DKK -1,179,474.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201801/01/2018 – 31/12/2018 | -276K | -294K | 8K | -1.2M | 0 | |
| 201701/01/2017 – 31/12/2017 | -239K | -277K | 21K | -886K | 0 | |
| 201601/01/2016 – 31/12/2016 | -272K | -345K | 146K | -608K | 0 | |
| 201501/01/2015 – 31/12/2015 | -426K | -488K | 526K | -263K | - | |
| 201401/01/2014 – 31/12/2014 | 4.7M | 2.8M | 1.3M | -1.9M | - | |
| 201301/01/2013 – 31/12/2013 | -2.6M | -3.7M | 6.7M | -4.7M | - | |
| 201201/01/2012 – 31/12/2012 | -1.1M | -2.5M | 3.3M | -3.5M | - |
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringNo. ENKAM PHARMACEUTICALS ApS is registered in the Danish CVR register with the status Dissolved and ceased on 15 July 2021.
The CVR number of ENKAM PHARMACEUTICALS ApS is 25812921.
In 2018, ENKAM PHARMACEUTICALS ApS reported a gross profit of DKK -275,740.
ENKAM PHARMACEUTICALS ApS had 1 employee in 2019 according to the Danish CVR register.
ENKAM PHARMACEUTICALS ApS was founded on 12 December 2000.
ENKAM PHARMACEUTICALS ApS was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi (industry code 721100).
ENKAM PHARMACEUTICALS ApS was dissolved on July 15, 2021.
As of January 11, 2021, Pernille Bigaard has stepped down as liquidator of ENKAM PHARMACEUTICALS ApS.
On January 11, 2021, ENKAM PHARMACEUTICALS ApS exited liquidation.
As of November 23, 2020, Pernille Bigaard is registered as liquidator of ENKAM PHARMACEUTICALS ApS.
On November 23, 2020, ENKAM PHARMACEUTICALS ApS entered liquidation.
As of September 22, 2020, Sven-Erik Lennart Nilsson has stepped down as adm. dir. of ENKAM PHARMACEUTICALS ApS.
As of August 17, 2020, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ENKAM PHARMACEUTICALS ApS.
ENKAM PHARMACEUTICALS ApS has published its annual report for 2018. Gross profit came to DKK -275,740, and the net result was DKK -293,665.
ENKAM PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK -239,433, and the net result was DKK -277,379.
As of May 31, 2018, Jan-Eric Østerlund has left the board of directors of ENKAM PHARMACEUTICALS ApS.
As of May 31, 2018, Sven-Erik Lennart Nilsson has left the board of directors of ENKAM PHARMACEUTICALS ApS.
As of May 31, 2018, Sven-Erik Lennart Nilsson is registered as adm. dir. of ENKAM PHARMACEUTICALS ApS.
As of May 31, 2018, Morten Albrechtsen has stepped down as director of ENKAM PHARMACEUTICALS ApS.
As of May 31, 2018, Robert George Mansfield has stepped down as chairman of ENKAM PHARMACEUTICALS ApS.
On May 31, 2018, the company changed its name from ENKAM PHARMACEUTICALS A/S to ENKAM PHARMACEUTICALS ApS.
ENKAM PHARMACEUTICALS ApS has published its annual report for 2016. Gross profit came to DKK -271,767, and the net result was DKK -345,030.
As of May 24, 2017, Jan Evert Lilja has left the board of directors of ENKAM PHARMACEUTICALS ApS.
ENKAM PHARMACEUTICALS ApS has published its annual report for 2015. Gross profit came to DKK -425,840, and the net result was DKK -488,005.
ENKAM PHARMACEUTICALS ApS has published its annual report for 2014. Gross profit came to DKK 4,669,049, and the net result was DKK 2,812,225.
ENKAM PHARMACEUTICALS ApS has published its annual report for 2013. Gross profit came to DKK -2,621,140, and the net result was DKK -3,665,105.
ENKAM PHARMACEUTICALS ApS has published its annual report for 2012. Gross profit came to DKK -1,060,280, and the net result was DKK -2,525,962.
As of December 27, 2011, Jan Evert Lilja has joined the board of directors of ENKAM PHARMACEUTICALS ApS.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ENKAM PHARMACEUTICALS ApS.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ENKAM PHARMACEUTICALS ApS.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of ENKAM PHARMACEUTICALS ApS.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ENKAM PHARMACEUTICALS ApS.
As of April 21, 2009, Jan-Eric Østerlund has joined the board of directors of ENKAM PHARMACEUTICALS ApS.
As of April 21, 2009, Elisabeth Marianne Bock has left the board of directors of ENKAM PHARMACEUTICALS ApS.
As of April 21, 2009, Volodymyr Berezin has left the board of directors of ENKAM PHARMACEUTICALS ApS.
As of April 21, 2009, Robert George Mansfield is registered as chairman of ENKAM PHARMACEUTICALS ApS.
As of December 9, 2008, Peter Holme Jensen has left the board of directors of ENKAM PHARMACEUTICALS ApS.
As of December 9, 2008, Jan-Eric Østerlund has left the board of directors of ENKAM PHARMACEUTICALS ApS.
As of August 29, 2008, Peter Holme Jensen has joined the board of directors of ENKAM PHARMACEUTICALS ApS.
As of August 29, 2008, Volodymyr Berezin has joined the board of directors of ENKAM PHARMACEUTICALS ApS.
As of August 29, 2008, Morten Albrechtsen has left the board of directors of ENKAM PHARMACEUTICALS ApS.
As of August 29, 2008, Robert George Mansfield has stepped down as chairman of ENKAM PHARMACEUTICALS ApS.
As of December 15, 2005, Morten Albrechtsen has joined the board of directors of ENKAM PHARMACEUTICALS ApS.
As of December 7, 2005, Jan-Eric Østerlund has joined the board of directors of ENKAM PHARMACEUTICALS ApS.
As of December 7, 2005, Jan Quistgaard has left the board of directors of ENKAM PHARMACEUTICALS ApS.
As of December 7, 2005, Robert George Mansfield is registered as chairman of ENKAM PHARMACEUTICALS ApS.
As of October 13, 2003, Jan Quistgaard has joined the board of directors of ENKAM PHARMACEUTICALS ApS.
As of August 16, 2002, A/S PSE NR. 4820 has been appointed auditor of ENKAM PHARMACEUTICALS ApS.
As of August 16, 2002, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has stepped down as auditor of ENKAM PHARMACEUTICALS ApS.
As of May 3, 2002, Sven Dyrløv Madsen has stepped down as chairman of ENKAM PHARMACEUTICALS ApS.
As of March 30, 2001, Sven-Erik Lennart Nilsson has joined the board of directors of ENKAM PHARMACEUTICALS ApS.
As of March 30, 2001, Volodymyr Berezin has left the board of directors of ENKAM PHARMACEUTICALS ApS.
As of March 30, 2001, Sven Dyrløv Madsen is registered as chairman of ENKAM PHARMACEUTICALS ApS.
On March 30, 2001, the company changed its name from ENKAM PHARMACEUTICALS ApS to ENKAM PHARMACEUTICALS A/S.
As of December 12, 2000, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of ENKAM PHARMACEUTICALS ApS.
As of December 12, 2000, Elisabeth Marianne Bock has joined the board of directors of ENKAM PHARMACEUTICALS ApS.
As of December 12, 2000, Volodymyr Berezin has joined the board of directors of ENKAM PHARMACEUTICALS ApS.
As of December 12, 2000, Morten Albrechtsen is registered as director of ENKAM PHARMACEUTICALS ApS.
ENKAM PHARMACEUTICALS ApS was founded on December 12, 2000.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
